Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 8.635.795.754.703.37

What is the latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of LINCOLN PHARMACEUTICALS is 8.63 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20248.63
Mar20235.79
Mar20225.75
Mar20214.70
Mar20203.37

How is EV/Core EBITDA of LINCOLN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 8.63
49.05
Mar2023 5.79
0.70
Mar2022 5.75
22.34
Mar2021 4.7
39.47
Mar2020 3.37 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,569.8 Cr -3.8% 24.7% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.8%

24.7%

31.4%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses